Developer docs
API playgroundTry for free, no card

Search company profiles

Millennium Health

Full company profile

uuid0007zrq

Namestring
Millennium Health
Legal namestring
Millennium Health LLC
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Millennium Health is an accredited specialty clinical laboratory providing definitive drug testing services to healthcare providers across the United States. The company's core offerings are Millennium UDT (urine drug testing) and Millennium OFT (oral fluid drug testing), both utilizing liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodology to detect more than 100 drugs and metabolites encompassing over 400 brand-name drugs. Testing is supported by the proprietary Intellium platform for test management and the RADAR reporting system, which delivers results within one business day with toxicologist consultation. The company is CAP-accredited, CLIA-certified for high-complexity testing, and holds HITRUST certification for the Intellium platform.

Millennium Health processes over one million specimens annually and has built a proprietary database of millions of clinical urine drug test results spanning all 50 states. This data asset underpins the Signals Report series (published since 2019), the Signals Alert emerging-threat notifications, and the Emerging Threat Intelligence (ETI) Program. The company publishes peer-reviewed studies in journals including JAMA Network Open, JAMA Psychiatry, Drug and Alcohol Dependence, and Journal of Opioid Management, and collaborates with the CDC, HHS, Ohio Department of Public Safety, Columbia University, and multiple academic medical centers.

The go-to-market model is direct enterprise field sales to prescribers in substance use disorder treatment, pain management, behavioral health, primary care, addiction treatment, obstetrics and gynecology, and multi-specialty group practices. Revenue is generated through fee-for-service laboratory testing billed to commercial payers (including UnitedHealthcare under a six-year Preferred Lab Network relationship), government programs, and patients. The company is privately held under the legal entity Millennium Health LLC, headquartered in San Diego, California, with CEO Scott Walton leading the organization since October 2021.

Short descriptiontext

Millennium Health is an accredited specialty clinical laboratory providing LC-MS/MS urine and oral fluid drug testing to healthcare providers across all 50 U.S. states, processing over one million specimens annually and publishing the proprietary Signals Report on drug use trends.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
urine drug testing, oral fluid drug testing, clinical laboratory services, medication monitoring, substance use disorder testing
Industry3 codes
1Toxicology & Therapeutic Drug Monitoring Laboratories
CodeHLAFAMAFPrimaryYes
2SaMD – Digital Biomarkers & Algorithmic Endpoints
CodeHLACANAFPrimaryNo
3DMPK / ADME & Bioanalysis
CodeHLAGAFACPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Drug Testing Services
TypeProfessional Services
Description

Fee-for-service laboratory testing for urine drug testing (UDT) and oral fluid drug testing (OFT) provided to healthcare providers across multiple specialties including substance use disorder treatment, pain management, behavioral health, and primary care. Services billed to payers including commercial insurance, government programs, and patients directly.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Millennium UDT
Description

Urine drug testing services allowing definitive detection of more than 100 drugs and metabolites.

+4 more records
Core offering1 text field

Millennium Health is an accredited specialty clinical laboratory that provides definitive urine drug testing (UDT) and oral fluid drug testing (OFT) using LC-MS/MS methodology to detect over 100 drugs and metabolites. Its services support clinicians in substance use disorder treatment, pain management, and behavioral health, and are delivered alongside the proprietary Intellium data platform and national drug use trend analytics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 85% of people testing positive for fentanyl in 2025 also tested positive for stimulants, with cocaine and methamphetamine detections exceeding heroin and prescription opioids in every U.S. state for the first time
+5 more records
Product overview1 text field

Millennium Health is an accredited specialty laboratory offering a comprehensive drug testing portfolio centered on two core testing services: Millennium UDT (urine drug testing) for definitive detection of 100+ drugs/metabolites across 400+ brand names, and Millennium OFT (oral fluid drug testing) as a convenient alternative. These core services are supported by the Intellium platform, which provides test management, data intelligence, and the RADAR reporting system with results delivered within one business day. The company also produces analytical intelligence products including the Signals Report (comprehensive national drug use trend analysis) and Signals Alert (timely emerging threat notifications). The portfolio is unified by a commitment to processing over a million specimens annually, enabling real-time analytics and collaboration with public health agencies including the CDC and HHS.

Product and service7 records
1Millennium UDT (Urine Drug Testing)
CategoryClinical Laboratory Services
Description

Definitive urine drug testing service using LC-MS/MS methodology that detects over 100 drugs and metabolites, offered to clinicians for substance use disorder treatment, pain management, and behavioral health decision support.

2Millennium OFT (Oral Fluid Drug Testing)
CategoryClinical Laboratory Services
Description

Definitive oral fluid drug testing service using LC-MS/MS methodology to detect over 100 drugs and metabolites, providing an alternative specimen type for clinicians needing rapid or observed collection.

3Continuum
CategoryClinical Laboratory Services
Description

Service program offered by Millennium Health to support clinicians in managing patients through definitive drug testing and clinical reporting.

4Intellium
CategoryHealthcare Data Analytics Platform
Description

Proprietary data intelligence and reporting platform that provides test management, data intelligence, and reporting for Millennium Health's drug testing services, including RADAR reporting for clinicians.

5Millennium Health Signals Report
CategoryDrug Use Trend Analytics
Description

National drug use trend analytics program that aggregates testing data across the United States to report on drug use patterns by region, drug class, and age group.

6Signals Alert
CategoryDrug Use Trend Analytics
Description

Alert product associated with the Signals Report program that notifies clinicians and stakeholders about emerging drug use trends or threats identified through Millennium Health's national testing data.

7Emerging Threat Intelligence (ETI) Program
CategoryDrug Use Trend Analytics
Description

Intelligence program offered by Millennium Health that monitors and reports on emerging substance use threats, supporting clinicians, treatment programs, and public health stakeholders with early warning insights.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-11-06
Description

Selected for UnitedHealthcare Preferred Lab Network for the sixth consecutive year, aligning with UHC's Triple Aim Focus on improving healthcare affordability, outcomes, and patient experience.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-07
Description

Multi-year contract where Millennium Health provides real-time urine drug testing data and analytics to CDC to support efforts to save lives and prevent fatal drug overdoses. CDC collaboration also includes clinical drug test dashboard for timely insights on shifting drug use trends.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-09-13
Description

Collaborative research at PAINWeek conference regarding illicit drug use among people with chronic pain, demonstrating urine specimens from pain management practices testing positive for heroin, illicit fentanyl, cocaine, and methamphetamine.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-08
Description

JAMA Network Open study demonstrating strong correlation between urine drug test results and drug overdose deaths, presenting new opportunity in fight against substance use crisis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-05-10
Description

NIDA-funded research collaboration to investigate precipitated withdrawal during buprenorphine induction, addressing treatment challenges for opioid use disorder.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-08-31
Description

Agreement to provide real-time drug use trends data through Emerging Threat Intelligence Program to aid Columbia's HEALing Communities Study efforts in New York to combat overdoses.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-09-09
Description

First state in the country to utilize Millennium Health's real-time drug use trends data to combat overdoses. Agreement provides real-time data to help direct public health responses to the substance use crisis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-07
Description

Agreement to provide real-time data to HHS as an aid in rapidly directing public health responses to the constantly evolving substance use epidemic. Includes co-authored JAMA study on drug use trends.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Aegis is the closest direct competitor to Millennium — a Nashville-based specialty clinical toxicology laboratory offering definitive urine drug testing using LC-MS/MS to pain management, behavioral health, and addiction treatment providers nationwide. Comparable business model, customer base, and test methodology.

TypeDirect peer
Description

Cordant is a specialty toxicology laboratory providing medication monitoring and drug testing services to addiction treatment, pain management, and behavioral health providers. Direct overlap with Millennium in UDT, oral fluid testing, and clinical decision support tools.

3United States Drug Testing Laboratories (USDTL)
TypeDirect peer
Description

USDTL is a specialty laboratory focused on substance use disorder testing, including definitive drug and alcohol testing using LC-MS/MS. Targets similar clinical segments including addiction treatment and pain management, competing head-to-head in UDT.

TypeDirect peer
Description

Dominion is a clinical laboratory specializing in urine drug testing and medication monitoring for substance use disorder and pain management. Provides comparable definitive LC-MS/MS testing services to a similar clinician customer base.

TypeBroad incumbent
Description

Quest is a national reference laboratory offering toxicology and drug testing as part of a broad menu. While Millennium's specialty focus differs from Quest's generalist model, Quest competes for the same clinical drug testing orders from healthcare providers.

TypeBroad incumbent
Description

LabCorp is a national clinical laboratory network that includes drug testing and toxicology services in its broad menu. Competes for healthcare provider drug testing volume alongside its wider diagnostic offerings.

TypeDirect peer
Description

CRL is a privately held clinical reference laboratory offering specialized toxicology and clinical drug testing services. Provides comparable UDT and medication monitoring to healthcare providers.

TypeDirect peer
Description

Precision Toxicology is a specialty clinical laboratory providing urine drug confirmation and pain management toxicology testing using LC-MS/MS. Competes in the same clinical drug testing category with a similar customer base.

TypeDirect peer
Description

Pacific Toxicology is a CLIA-certified specialty laboratory offering clinical and forensic drug testing services. Provides urine drug testing with comparable methodology to Millennium's clinical clientele.

TypeBroad incumbent
Description

Eurofins is a global laboratory services group with clinical diagnostics and toxicology testing capabilities in the U.S. market. While much broader than Millennium, Eurofins competes for clinical drug testing volume through its clinical diagnostics network.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Millennium Health

Clinical Laboratory Servicesmillenniumhealth.com

Millennium Health is an accredited specialty clinical laboratory providing LC-MS/MS urine and oral fluid drug testing to healthcare providers across all 50 U.S. states, processing over one million specimens annually and publishing the proprietary Signals Report on drug use trends.

What Millennium Health does

Millennium Health is an accredited specialty clinical laboratory providing definitive drug testing services to healthcare providers across the United States. The company's core offerings are Millennium UDT (urine drug testing) and Millennium OFT (oral fluid drug testing), both utilizing liquid chromatography-tandem mass spectrometry (LC-MS/MS) methodology to detect more than 100 drugs and metabolites encompassing over 400 brand-name drugs. Testing is supported by the proprietary Intellium platform for test management and the RADAR reporting system, which delivers results within one business day with toxicologist consultation. The company is CAP-accredited, CLIA-certified for high-complexity testing, and holds HITRUST certification for the Intellium platform.

Millennium Health processes over one million specimens annually and has built a proprietary database of millions of clinical urine drug test results spanning all 50 states. This data asset underpins the Signals Report series (published since 2019), the Signals Alert emerging-threat notifications, and the Emerging Threat Intelligence (ETI) Program. The company publishes peer-reviewed studies in journals including JAMA Network Open, JAMA Psychiatry, Drug and Alcohol Dependence, and Journal of Opioid Management, and collaborates with the CDC, HHS, Ohio Department of Public Safety, Columbia University, and multiple academic medical centers.

The go-to-market model is direct enterprise field sales to prescribers in substance use disorder treatment, pain management, behavioral health, primary care, addiction treatment, obstetrics and gynecology, and multi-specialty group practices. Revenue is generated through fee-for-service laboratory testing billed to commercial payers (including UnitedHealthcare under a six-year Preferred Lab Network relationship), government programs, and patients. The company is privately held under the legal entity Millennium Health LLC, headquartered in San Diego, California, with CEO Scott Walton leading the organization since October 2021.

Millennium Health firmographics

Firmographics
Name
Millennium Health
Legal name
Millennium Health LLC
Website
https://millenniumhealth.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Millennium Health is an accredited specialty clinical laboratory providing LC-MS/MS urine and oral fluid drug testing to healthcare providers across all 50 U.S. states, processing over one million specimens annually and publishing the proprietary Signals Report on drug use trends.
Ownership category
akta.pro rank

Millennium Health industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)
akta.pro secondary industries
SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), DMPK / ADME & Bioanalysis (HLAGAFAC)

Keywords

  • Urine drug testing
  • Oral fluid drug testing
  • Clinical laboratory services
  • Medication monitoring
  • Substance use disorder testing

Where Millennium Health is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Millennium Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Drug Testing Services: Fee-for-service laboratory testing for urine drug testing (UDT) and oral fluid drug testing (OFT) provided to healthcare providers across multiple specialties including substance use disorder treatment, pain management, behavioral health, and primary care. Services billed to payers including commercial insurance, government programs, and patients directly.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Millennium Health product offering

Product offering

Core offering

Millennium Health is an accredited specialty clinical laboratory that provides definitive urine drug testing (UDT) and oral fluid drug testing (OFT) using LC-MS/MS methodology to detect over 100 drugs and metabolites. Its services support clinicians in substance use disorder treatment, pain management, and behavioral health, and are delivered alongside the proprietary Intellium data platform and national drug use trend analytics.

Product overview

Millennium Health is an accredited specialty laboratory offering a comprehensive drug testing portfolio centered on two core testing services: Millennium UDT (urine drug testing) for definitive detection of 100+ drugs/metabolites across 400+ brand names, and Millennium OFT (oral fluid drug testing) as a convenient alternative. These core services are supported by the Intellium platform, which provides test management, data intelligence, and the RADAR reporting system with results delivered within one business day. The company also produces analytical intelligence products including the Signals Report (comprehensive national drug use trend analysis) and Signals Alert (timely emerging threat notifications). The portfolio is unified by a commitment to processing over a million specimens annually, enabling real-time analytics and collaboration with public health agencies including the CDC and HHS.

Differentiator

Problem solved

Functional benefit

Brands

  • Millennium UDT: Urine drug testing services allowing definitive detection of more than 100 drugs and metabolites.
  • Millennium OFT
  • Intellium
  • RADAR Report
  • Continuum

Products and services

  • Millennium UDT (Urine Drug Testing) Definitive urine drug testing service using LC-MS/MS methodology that detects over 100 drugs and metabolites, offered to clinicians for substance use disorder treatment, pain management, and behavioral health decision support.
  • Millennium OFT (Oral Fluid Drug Testing) Definitive oral fluid drug testing service using LC-MS/MS methodology to detect over 100 drugs and metabolites, providing an alternative specimen type for clinicians needing rapid or observed collection.
  • Continuum Service program offered by Millennium Health to support clinicians in managing patients through definitive drug testing and clinical reporting.
  • Intellium Proprietary data intelligence and reporting platform that provides test management, data intelligence, and reporting for Millennium Health's drug testing services, including RADAR reporting for clinicians.
  • Millennium Health Signals Report National drug use trend analytics program that aggregates testing data across the United States to report on drug use patterns by region, drug class, and age group.
  • Signals Alert Alert product associated with the Signals Report program that notifies clinicians and stakeholders about emerging drug use trends or threats identified through Millennium Health's national testing data.
  • Emerging Threat Intelligence (ETI) Program Intelligence program offered by Millennium Health that monitors and reports on emerging substance use threats, supporting clinicians, treatment programs, and public health stakeholders with early warning insights.

Quantifiable outcome

  • 85% of people testing positive for fentanyl in 2025 also tested positive for stimulants, with cocaine and methamphetamine detections exceeding heroin and prescription opioids in every U.S. state for the first time
  • +5 more outcomes

Companies that use Millennium Health

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Millennium Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Millennium Health partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • UnitedHealthcarecoreChannel Partner/ Reseller/ Distributor · 6 November 2025Selected for UnitedHealthcare Preferred Lab Network for the sixth consecutive year, aligning with UHC's Triple Aim Focus on improving healthcare affordability, outcomes, and patient experience.
  • Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development Partner · 7 February 2023Multi-year contract where Millennium Health provides real-time urine drug testing data and analytics to CDC to support efforts to save lives and prevent fatal drug overdoses. CDC collaboration also includes clinical drug test dashboard for timely insights on shifting drug use trends.
  • Penn State College of MedicineminorStrategic or Co-development Partner · 13 September 2022Collaborative research at PAINWeek conference regarding illicit drug use among people with chronic pain, demonstrating urine specimens from pain management practices testing positive for heroin, illicit fentanyl, cocaine, and methamphetamine.
  • Ohio State University College of MedicinecoreStrategic or Co-development Partner · 8 June 2022JAMA Network Open study demonstrating strong correlation between urine drug test results and drug overdose deaths, presenting new opportunity in fight against substance use crisis.
  • University of CincinnaticoreStrategic or Co-development Partner · 10 May 2022NIDA-funded research collaboration to investigate precipitated withdrawal during buprenorphine induction, addressing treatment challenges for opioid use disorder.
  • Columbia UniversitycoreStrategic or Co-development Partner · 31 August 2021Agreement to provide real-time drug use trends data through Emerging Threat Intelligence Program to aid Columbia's HEALing Communities Study efforts in New York to combat overdoses.
  • Ohio Department of Public SafetycoreStrategic or Co-development Partner · 9 September 2020First state in the country to utilize Millennium Health's real-time drug use trends data to combat overdoses. Agreement provides real-time data to help direct public health responses to the substance use crisis.
  • U.S. Department of Health and Human Services (HHS)coreStrategic or Co-development Partner · 7 January 2020Agreement to provide real-time data to HHS as an aid in rapidly directing public health responses to the constantly evolving substance use epidemic. Includes co-authored JAMA study on drug use trends.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Millennium Health competitors and assessment

Company assessment

Direct peers

  • Aegis Sciences Corporation: Aegis is the closest direct competitor to Millennium — a Nashville-based specialty clinical toxicology laboratory offering definitive urine drug testing using LC-MS/MS to pain management, behavioral health, and addiction treatment providers nationwide. Comparable business model, customer base, and test methodology.
  • Cordant Health Solutions: Cordant is a specialty toxicology laboratory providing medication monitoring and drug testing services to addiction treatment, pain management, and behavioral health providers. Direct overlap with Millennium in UDT, oral fluid testing, and clinical decision support tools.
  • United States Drug Testing Laboratories (USDTL): USDTL is a specialty laboratory focused on substance use disorder testing, including definitive drug and alcohol testing using LC-MS/MS. Targets similar clinical segments including addiction treatment and pain management, competing head-to-head in UDT.
  • Dominion Diagnostics: Dominion is a clinical laboratory specializing in urine drug testing and medication monitoring for substance use disorder and pain management. Provides comparable definitive LC-MS/MS testing services to a similar clinician customer base.
  • Clinical Reference Laboratory (CRL): CRL is a privately held clinical reference laboratory offering specialized toxicology and clinical drug testing services. Provides comparable UDT and medication monitoring to healthcare providers.
  • Precision Toxicology: Precision Toxicology is a specialty clinical laboratory providing urine drug confirmation and pain management toxicology testing using LC-MS/MS. Competes in the same clinical drug testing category with a similar customer base.
  • Pacific Toxicology Laboratories: Pacific Toxicology is a CLIA-certified specialty laboratory offering clinical and forensic drug testing services. Provides urine drug testing with comparable methodology to Millennium's clinical clientele.

Broad incumbents

  • Quest Diagnostics: Quest is a national reference laboratory offering toxicology and drug testing as part of a broad menu. While Millennium's specialty focus differs from Quest's generalist model, Quest competes for the same clinical drug testing orders from healthcare providers.
  • Laboratory Corporation of America (LabCorp): LabCorp is a national clinical laboratory network that includes drug testing and toxicology services in its broad menu. Competes for healthcare provider drug testing volume alongside its wider diagnostic offerings.
  • Eurofins Scientific: Eurofins is a global laboratory services group with clinical diagnostics and toxicology testing capabilities in the U.S. market. While much broader than Millennium, Eurofins competes for clinical drug testing volume through its clinical diagnostics network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Millennium Health social profiles

Digital presence

Millennium Health compliance and trust

Trust signal

Compliance3 records

Millennium Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Millennium Health leadership team

Management profile

Number of profiles

Profiles6 records

Millennium Health funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Millennium Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Millennium Health

What does Millennium Health do?

Millennium Health is an accredited specialty clinical laboratory that provides definitive urine drug testing (UDT) and oral fluid drug testing (OFT) using LC-MS/MS methodology to detect over 100 drugs and metabolites. Its services support clinicians in substance use disorder treatment, pain management, and behavioral health, and are delivered alongside the proprietary Intellium data platform and national drug use trend analytics.

Is Millennium Health a public or private company?

Millennium Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Millennium Health founded?

Millennium Health was founded in 2010. It employs 1,001 to 5,000 people.

Where is Millennium Health based?

Millennium Health is headquartered in San Diego, United States, in the North America region.

How does Millennium Health make money?

One revenue line is on record: clinical Drug Testing Services.

Who are Millennium Health's main competitors?

Direct peers on record are Aegis Sciences Corporation, Cordant Health Solutions, United States Drug Testing Laboratories (USDTL), Dominion Diagnostics, Clinical Reference Laboratory (CRL), Precision Toxicology and Pacific Toxicology Laboratories. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (LabCorp) and Eurofins Scientific.

Does Millennium Health have an API?

No public API is recorded for Millennium Health.

What industry is Millennium Health in?

Millennium Health's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestThe CDC's New Overdose Metric Runs on Paid Drug Tests from One Private LabThe CDC launched a dashboard tracking fentanyl, heroin, cocaine, and methamphetamine in drug tests from Millennium Health, a private lab. The dashboard shows a 12.3% drop in overdose deaths for 2025, but fentanyl exposure remains high in the West. The CDC notes the data is a convenience sample, not a census.EIN PresswireNew Study Shows Urine Drug Testing Data Serve as Powerful Early Warning System, Help to Explain Regional Changes in Fatal OverdoseA study of over 2.1 million urine drug testing specimens found fentanyl detection rates and concentrations closely tracked with synthetic opioid overdose deaths. Fentanyl detection rates rose 104% and concentrations 333% from 2019-2023, then fell 25% and 28% in 2024, mirroring DEA purity declines. The findings suggest UDT data can serve as a real-time early warning system for regional overdose changes.EIN PresswireMillennium Health and CDC Collaborate on Clinical Drug Test DashboardMillennium Health supplied urine drug testing data for a new CDC dashboard tracking national and regional trends in fentanyl, heroin, cocaine, methamphetamine, and polysubstance use. The dashboard reports quarterly and six-month trends, and CDC will roll it out to state and local health departments.EIN PresswireFentanyl Overdose Deaths Plummet but Unchecked Illicit Stimulant Use Threatens to Reshape America’s Drug Use EpidemicMillennium Health released its 2026 Signals Report showing the most sustained national decline in fentanyl overdose deaths in two decades, based on analysis of over 1.69 million clinical urine drug tests collected from 2016-2025. However, the findings reveal a sharp surge in illicit stimulant use: 85% of people testing positive for fentanyl in 2025 also tested positive for stimulants, and cocaine and methamphetamine detections exceeded heroin and prescription opioids in every U.S. state for the first time. The report highlights a growing gap between the scale of stimulant use and available clinical treatment options, with clinicians managing increasingly complex polysubstance use patterns without adequate therapeutic tools.EIN PresswireCannabis Use Detection, Concentrations Rise Among Young People; Gender Gap in Cannabis Use NarrowsA report by Millennium Health shows increasing detection of cannabis use among young people with substance use disorder, with significant rises in THC levels from 2019 to 2025. The detection rates have grown faster among females, and THC levels have nearly doubled among adolescents and young adults. The report highlights growing health concerns and gender disparities in cannabis use.AxiosFentanyl-positive patients usually had additional drugs in their systemsA Millennium Health report of 4.5 million drug tests found that nearly every fentanyl-positive patient also had other substances, with over 43% of fentanyl-positive tests positive for up to three additional drugs. Methamphetamine, prescription opioids, cocaine, and heroin were the most common, and fentanyl analogs appeared in over 60% of fentanyl-positive tests. The West Coast saw spikes 10-11 times higher than 2019 levels.PR NewswireOregon Experiencing Substantial Increase in Fentanyl Use for 2022Millennium Health released a report finding that Oregon experienced a 58% increase in fentanyl positivity in Q1 2022 compared to all of 2021, with Jackson County showing a 197% increase and Umatilla County an 88% increase. The report identified Oregon as one of only four states with significant illicit fentanyl increases in March 2022, noting that statewide fentanyl positivity has risen 163% since 2020. The CDC reported that Oregon overdose deaths increased 36% compared to a 16% national increase.PR NewswireMillennium Health Signals Report™ Volume 4 Highlights Substantial Changes in Illicit Drug Use TrendsMillennium Health released its Signals Report Volume 4 analyzing 2 million unique patient urine specimens collected through December 2021, revealing substantial increases in illicit drug use across the United States. Key findings include a 427% increase in fentanyl positivity in the Pacific census division, a 571% increase in fentanyl and methamphetamine co-positivity in the same region, and a 134% increase in methamphetamine positivity in New England. The report comes as U.S. drug overdose deaths reach record highs, primarily driven by illicit fentanyl and methamphetamine, and is intended to inform public health interventions and serve as an early warning system for overdose risk.PR NewswireMillennium Health Appoints Scott Walton as Chief Executive OfficerMillennium Health, a specialty medication monitoring and drug testing company, announced the appointment of Scott Walton as Chief Executive Officer effective immediately. Walton brings over twenty years of experience in clinical diagnostics, having previously served as CEO at Ameritox and Inform Diagnostics, and most recently as Executive Vice President of esoteric testing at LabCorp. The company states that medication monitoring and drug testing are critical for addressing healthcare and public health challenges.PR NewswireMillennium Health Study Published In Drug And Alcohol Dependence Highlights Covid-19, Seasonal And Regional Influences On Alcohol ConsumptionMillennium Health published a study in Drug and Alcohol Dependence analyzing 2 million patient urine specimens collected across all 50 U.S. states from 2013-2020, finding 16.73% positive for alcohol. The research identified a small but significant increase in alcohol positivity during the COVID-19 pandemic timeframe, along with seasonal variation (highest in summer, lowest in winter) and demographic patterns with males aged 45-64 most likely to test positive. The study aims to help identify patients at increased risk and improve clinical decision-making in healthcare settings.